Bayer brand A1CNow+ MULTI-TEST A1C SYSTEM TEST KITS (PART NUMBER 3021/08842610); Hemoglobin A1c Monitor; Glycosylated Hemoglobin Assay; Product is manufactured and distributed by Bayer HealthCare LLC, Sunnyvale, CA The A1CNow+ test provides quantitative measurement of the percent of glycated hemoglobin (%HbA1c or %A1C) levels in capillary (fingerstick) or venous whole blood samples. The test is for professional use to monitor glycemic control in people with diabetes.
Published November 13, 2013 · Recall initiated: August 26, 2013
Summary
FDA records medical device Class II recall Z-0136-2014, published November 13, 2013 and initiated August 26, 2013. Recalling firm: Bayer Healthcare Llc; Status: Terminated; Reported quantity: 138 Kits in US (Total 2452); Lot: Lot: 1300733 (US, China); Lot: 1300712 (Argentina, Uruguay); Lots: 1300711, 130012 (Japan). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Test results from these lots may produce a high-bias reading (by up to 20%) that is outside of limits defined for stability and product accuracy when product is stored at room temperature four (4) to five (5) months after release.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Bayer Healthcare Llc
- Distributor
- Worldwide Distribution - USA (nationwide) and Internationally to China, Argentina, Uruguay, Japan.
- Lot
- Lot: 1300733 (US, China); Lot: 1300712 (Argentina, Uruguay); Lots: 1300711, 130012 (Japan)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAEdwards Lifesciences Dispersion Aortic Perfusion Cannula with Duraflo Coating, Sterile, RX only For Single UseNovember 13, 2013
- FDASurgicutt fully automated incision making device for bleeding time determination. ITC 8 Olsen Avenue, Edison,November 13, 2013
- FDAEdwards Lifesciences Fem-Flex Femoral Arterial Cannula with Duraflo Coating, DIITFA02225, Sterile, RX only ForNovember 13, 2013
- FDAStereotactic Circular Collimator - 3D Line stereotatic Hardware Accessories The device is part of the class ofNovember 13, 2013
- FDAThe EkoSonic Endovascular System employs high frequency (2-2.5 MHz), low power (0.585 watt average power perNovember 13, 2013
- FDAPatient Cart used in conjunction with the da Vinci S surgical and SI System. Intuitive Surgical 1266 KiferNovember 13, 2013
Questions about this recall
Was Bayer brand A1CNow+ MULTI-TEST A1C SYSTEM TEST KITS (PART NUMBER 3021/08842610); Hemoglobin A1c Monitor; Glycosylated Hemoglobin Assay; Product is manufactured and distributed by Bayer HealthCare LLC, Sunnyvale, CA The A1CNow+ test provides quantitative measurement of the percent of glycated hemoglobin (%HbA1c or %A1C) levels in capillary (fingerstick) or venous whole blood samples. The test is for professional use to monitor glycemic control in people with diabetes. recalled?
Yes. FDA published recall Z-0136-2014 on November 13, 2013. Reported hazard: Test results from these lots may produce a high-bias reading (by up to 20%) that is outside of limits defined for stability and product accuracy when product is stored at room temperature four (4) to five (5) months after release.
What should I do if I have this product?
Voluntary: Firm initiated · Letter